GIM
ABBV icon

Groesbeck Investment Management’s AbbVie ABBV Stock Holding History

Groesbeck Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$794K Hold
3,155
– – 1.26% 20
2026
Q1 		$686K Hold
3,155
– – 1.34% 23
2025
Q4 		$721K Hold
3,155
– – 1.36% 24
2025
Q3 		$731K Sell
3,155
-3,400
-52% -$692K 1.43% 25
2025
Q2 		$1.22M Sell
6,555
-13,000
-66% -$2.42M 2.14% 16
2025
Q1 		$4.1M Hold
19,555
– – 5.73% 1
2024
Q4 		$3.48M Buy
19,555
+12,276
+169% +$2.26M 4.52% 3
2024
Q3 		$1.44M Hold
7,279
– – 2.11% 15
2024
Q2 		$1.25M Sell
7,279
-15,084
-67% -$2.5M 1.73% 16
2024
Q1 		$4.07M Buy
22,363
+13,000
+139% +$2.24M 4.33% 4
2023
Q4 		$1.45M Sell
9,363
-2,600
-22% -$379K 2.01% 14
2023
Q3 		$1.78M Sell
11,963
-427
-3% -$62.7K 2.7% 9
2023
Q2 		$1.67M Sell
12,390
-8,229
-40% -$1.21M 2.54% 9
2023
Q1 		$3.29M Sell
20,619
-218
-1% -$33.3K 4.93% 1
2022
Q4 		$3.37M Sell
20,837
-110
-0.5% -$16.9K 5.64% 1
2022
Q3 		$3.21M Hold
20,947
– – 5.29% 1
2022
Q2 		$3.21M Sell
20,947
-14,347
-41% -$2.19M 5.29% 1
2022
Q1 		$5.72M Buy
35,294
+12,990
+58% +$1.89M 6.41% 1
2021
Q4 		$3.02M Sell
22,304
-13,010
-37% -$1.54M 3.84% 4
2021
Q3 		$3.81M Buy
35,314
+11,555
+49% +$1.32M 4.4% 1
2021
Q2 		$2.68M Buy
23,759
+1,137
+5% +$128K 3.41% 4
2021
Q1 		$2.45M Buy
22,622
+800
+4% +$85.6K 3.53% 4
2020
Q4 		$2.34M Sell
21,822
-70
-0.3% -$6.73K 3.83% 2
2020
Q3 		$1.92M Sell
21,892
-1,000
-4% -$94.1K 3.59% 3
2020
Q2 		$2.25M Sell
22,892
-190
-0.8% -$16.7K 4.45% 1
2020
Q1 		$1.76M Sell
23,082
-50,657
-69% -$4.31M 4.72% 1
2019
Q4 		$6.53M Sell
73,739
-2,176
-3% -$181K 4.82% 2
2019
Q3 		$5.75M Buy
75,915
+2,208
+3% +$151K 4.31% 2
2019
Q2 		$5.36M Sell
73,707
-1,157
-2% -$90.9K 4.36% 2
2019
Q1 		$6.03M Buy
74,864
+66
+0.1% +$5.4K 4.6% 2
2018
Q4 		$6.9M Sell
74,798
-917
-1% -$80.6K 5.88% 1
2018
Q3 		$7.16M Sell
75,715
-924
-1% -$87.6K 4.87% 1
2018
Q2 		$7.1M Sell
76,639
-220
-0.3% -$21.5K 4.97% 1
2018
Q1 		$7.28M Sell
76,859
-1,981
-3% -$218K 5.27% 1
2017
Q4 		$7.63M Sell
78,840
-753
-0.9% -$71K 5.35% 1
2017
Q3 		$7.07M Sell
79,593
-781
-1% -$59.5K 5.09% 1
2017
Q2 		$5.83M Sell
80,374
-26,384
-25% -$1.77M 4.31% 2
2017
Q1 		$6.96M Sell
106,758
-969
-0.9% -$60.9K 5.17% 1
2016
Q4 		$6.75M Sell
107,727
-12,113
-10% -$739K 5.27% 1
2016
Q3 		$7.56M Sell
119,840
-7,905
-6% -$512K 5.61% 1
2016
Q2 		$7.91M Sell
127,745
-70
-0.1% -$4.26K 5.78% 1
2016
Q1 		$7.3M Buy
127,815
+33,354
+35% +$1.86M 5.22% 1
2015
Q4 		$5.6M Buy
94,461
+13,316
+16% +$767K 3.56% 6
2015
Q3 		$4.42M Sell
81,145
-2,398
-3% -$156K 2.78% 13
2015
Q2 		$5.61M Sell
83,543
-570
-0.7% -$37.2K 2.69% 11
2015
Q1 		$4.92M Sell
84,113
-3,367
-4% -$203K 2.39% 18
2014
Q4 		$5.72M Sell
87,480
-3,920
-4% -$247K 2.81% 8
2014
Q3 		$5.28M Sell
91,400
-9,514
-9% -$528K 2.51% 12
2014
Q2 		$5.7M Sell
100,914
-3,616
-3% -$190K 2.48% 11
2014
Q1 		$5.37M Sell
104,530
-42,370
-29% -$2.14M 2.42% 15
2013
Q4 		$7.76M Sell
146,900
-4,639
-3% -$228K 3.22% 3
2013
Q3 		$6.78M Sell
151,539
-4,988
-3% -$221K 2.94% 9
2013
Q2 		$6.47M Buy
+156,527
New +$6.85M 2.73% 11

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Groesbeck Investment Management's ABBV Position: Q2 2026 in Review

Groesbeck Investment Management held its AbbVie (ABBV) position steady in Q2 2026 at 3,155 shares worth $794K. The position accounts for 1.26% of the portfolio, ranked #20.

Groesbeck Investment Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.91M in Q2 2016. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Groesbeck Investment Management held 3,155 shares of AbbVie worth $794K as of Q2 2026.
  • Groesbeck Investment Management left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 1.26% of Groesbeck Investment Management's portfolio in Q2 2026, its #20 holding.
  • Groesbeck Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • Groesbeck Investment Management's AbbVie position peaked at $7.91M in Q2 2016.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Groesbeck Investment Management's 13F filing for Q2 2026, filed 15 Jul 2026.